NKGen Biotech, Inc.
NKGNDelisted Jul 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001845459
NKGen Biotech, Inc. was delisted on Jul 17, 2025; its insiders filed their last Form 4 on Jun 2, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding NKGen Biotech, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 3.75M | +3.75M |
| Value | $0 | $13.7M | +$13.7M |
New holders (9)
Institutions that held NKGen Biotech, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sandia Investment Management LP | 442,622 | $4.61M | 3.21% |
| Meteora Capital, LLC | 1,596,817 | $4.39M | 0.75% |
| Polar Asset Management Partners Inc. | 1,080,000 | $2.94M | 0.08% |
| University of Chicago | 550,000 | $1.51M | 2.10% |
| Geode Capital Management, LLC | 45,850 | $126.1K | 0.00% |
| Millennium Management LLC | 18,394 | $50.6K | 0.00% |
| Northern Trust Corp | 15,722 | $43.2K | 0.00% |
| Federation des caisses Desjardins du Quebec | 500 | $1.38K | 0.00% |
| Wells Fargo & Company | 47 | $129 | 0.00% |
Sold out (0)
Institutions that held NKGen Biotech, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
None.